Given the efficacy of SSTNIGF1R against HNSCC cell lines and PDXs, we used PLA as a biomarker for the Sdc1:IGF1R:ITGAV receptor complex in archival tumors. The gene discussed is SDC1; the disease is head and neck squamous cell carcinoma.